Insights

PremiOM™ PsO Dataset Overview

133,800+

Patients with deep clinical data including clinical notes from dermatologists

7.4 years

Mean follow up
per patient

98%

With linked EMR &
medical claims

PremiOM PsO Dataset Highlights

*PremiOM PsO Dataset counts through Q3 2023

Representative | Understanding Patient Subtypes

OM1 PsO is highly representative of the PsO population.
Psoriasis is slightly more prevalent in women than men and occurs more frequently in Whites than in minority races, at any age.

The typical onset of PsO occurs in early adulthood between the ages of 30 and 39 years or later from 50 and 69 years, although it can present at any age.

Comprehensive | Geographic Representativeness

OM1's PsO population is closely representative of the U.S. Census distribution.

Longitudinal | Evaluating Treatment Patterns

The breadth of medications available in the PsO dataset derive from robust linked EMR and claims data.
Biologics have been a life-changing treatment option for patients with moderate to severe psoriasis for nearly two decades.

Patients may switch biologics to a different type for a number of reasons such as inefficacy.
As shown in the blinded illustration, the longitudinal nature of the data captures patients with biologic switches.

Robust | Disease Activity Insights

Several key findings are made available in OM1's PremiOM PsO clinically deep data through ongoing and advanced notes extraction and estimation of outcomes such as those represented below that allow researchers to develop insights.

Disease characteristics frequently captured in clinical notes such as itch severity, location, and physician administered assessments BSA, and PGA are traditionally hard to find or challenging to work with in a meaningful way.

33,000

Patients with Psoriasis Subtype

3,300

Patients with PsO Severity

2,800

Patients with Itch Severity

1,300

Patients with Psoriasis Location

90,900

Patients with % Body Surface Area

7,000

Patients with Physician Global Assessment

Clinically Deep | Analyzing PsO Locations

OM1’s augmentation of our rich foundational data through automated and manual note abstractions reveals PsO locations.

Shown are patient volumes for traditionally hard to find psoriasis locations of scalp, nail, and hand/foot.